Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice

BACKGROUND: Human metapneumovirus (HMPV) causes respiratory tract infections among infant, elderly, and immunocompromised patients, with significant mortality. Currently no licensed vaccines or therapeutic agents of HMPV exist. METHODS: HMPV virus-like particle (VLP) was constructed by co-expressing...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Fenlian, Chen, Aijun, Yao, Lihong, Gao, Hanchun, Zhang, Qian, Hou, Wenzhe, Zheng, Lishu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491852/
https://www.ncbi.nlm.nih.gov/pubmed/37657510
http://dx.doi.org/10.1016/j.virusres.2023.199215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491852/
https://www.ncbi.nlm.nih.gov/pubmed/37657510
http://dx.doi.org/10.1016/j.virusres.2023.199215

Ejemplares similares